Literature DB >> 8496106

Use of fenbendazole for treatment of Crenosoma vulpis infection in a dog.

E N Peterson1, S C Barr, W J Gould, K A Beck, D D Bowman.   

Abstract

An 8-month-old Labrador Retriever was examined because of a 1-month history of productive coughing unresponsive to ampicillin treatment. Larvae of Crenosoma vulpis were found in fecal samples examined by zinc sulfate centrifugation and Baermann technique. Physical examination abnormalities or larvae in fecal samples were not detected 6 weeks after treatment with prednisone (1 mg/kg, PO, q 24 h, for 7 days, then 0.5 mg/kg, PO, q 48 h, for 8 days) and fenbendazole granules (50 mg/kg, PO, q 24 h, for 3 days). This report suggests that fenbendazole may be effective for treating Crenosoma vulpis infection in dogs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496106

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Eosinophilic bronchitis caused by Crenosoma vulpis infection in dogs.

Authors:  D H Shaw; G A Conboy; P M Hogan; B S Horney
Journal:  Can Vet J       Date:  1996-06       Impact factor: 1.008

2.  Lungworm (Crenosoma vulpis) infection in dogs on Prince Edward Island.

Authors:  T Bihr; G A Conboy
Journal:  Can Vet J       Date:  1999-08       Impact factor: 1.008

Review 3.  A review of the pathology and treatment of canine respiratory infections.

Authors:  Miranda D Vieson; Pablo Piñeyro; Tanya LeRoith
Journal:  Vet Med (Auckl)       Date:  2012-06-26

4.  Canine and feline cardiopulmonary parasitic nematodes in Europe: emerging and underestimated.

Authors:  Donato Traversa; Angela Di Cesare; Gary Conboy
Journal:  Parasit Vectors       Date:  2010-07-23       Impact factor: 3.876

5.  Efficacy of a single topical application of Advantage Multi (= Advocate) Topical Solution (10% imidocloprid + 2.5% moxidectin) in the treatment of dogs experimentally infected with Crenosoma vulpis.

Authors:  Gary Conboy; Jonathan Hare; Sam Charles; Terry Settje; Josef Heine
Journal:  Parasitol Res       Date:  2009-08       Impact factor: 2.289

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.